Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2
- 31 July 2009
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 114 (1), 53-56
- https://doi.org/10.1016/j.ygyno.2009.03.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of obesity on survival in patients with ovarian cancerGynecologic Oncology, 2009
- Body mass index and risk of ovarian cancerCancer, 2009
- Body size and risk of epithelial ovarian and related cancers: A population‐based case‐control studyInternational Journal of Cancer, 2008
- Breast cancer adjuvant chemotherapy dosing in obese patientsCancer, 2008
- Effect of obesity on survival in epithelial ovarian cancerCancer, 2006
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Actual Body Weight for Determining Doses of Chemotherapy in Obese Cancer Patients: Evaluation of Treatment TolerabilityMedical Oncology, 2003
- Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.Journal of Clinical Oncology, 1996
- Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast CarcinomaNew England Journal of Medicine, 1994